Cargando…
Combined therapeutic benefit of mitochondria-targeted antioxidant, MitoQ(10), and angiotensin receptor blocker, losartan, on cardiovascular function
OBJECTIVE: Mitochondria-derived reactive oxygen species (ROS) play important roles in the development of cardiovascular disease highlighting the need for novel targeted therapies. This study assessed the potential therapeutic benefit of combining the mitochondria-specific antioxidant, MitoQ(10), wit...
Autores principales: | McLachlan, Jennifer, Beattie, Elisabeth, Murphy, Michael P., Koh-Tan, Caline H.H., Olson, Erin, Beattie, Wendy, Dominiczak, Anna F., Nicklin, Stuart A., Graham, Delyth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914904/ https://www.ncbi.nlm.nih.gov/pubmed/24309493 http://dx.doi.org/10.1097/HJH.0000000000000054 |
Ejemplares similares
-
Mitochondria-targeted antioxidant therapy with MitoQ ameliorates aortic stiffening in old mice
por: Gioscia-Ryan, Rachel A., et al.
Publicado: (2018) -
The mitochondria-targeted antioxidant MitoQ, attenuates exercise-induced mitochondrial DNA damage
por: Williamson, Josh, et al.
Publicado: (2020) -
MitoQ Is Able to Modulate Apoptosis and Inflammation
por: Piscianz, Elisa, et al.
Publicado: (2021) -
Protection against renal ischemia–reperfusion injury in vivo by the mitochondria targeted antioxidant MitoQ
por: Dare, Anna J., et al.
Publicado: (2015) -
Dissecting the genetic components of a quantitative trait locus for blood pressure and renal pathology on rat chromosome 3
por: Koh-Tan, H.H. Caline, et al.
Publicado: (2017)